ClinicalTrialsFinder

Refractory Primary Mediastinal Large B-Cell Lymphoma Clinical Trials in Rochester, Minnesota

1 recruitingRochester, Minnesota

Showing 1–1 of 1 trials

Recruiting
Phase 2

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

Recurrent Grade 3b Follicular LymphomaRefractory Grade 3b Follicular LymphomaRecurrent Transformed Non-Hodgkin Lymphoma+28 more
Mayo Clinic41 enrolled7 locationsNCT06834373